Cell therapy commercialisation
D. Brindley and C. Mason, University College London UK
‘Cells as therapies’ is a major step change in healthcare. Living cells offer solutions for a range of currently incurable medical conditions; however, both the technology and its essential infrastructure are far from market ready. Despite the limitations of any fledgling technology, the global cell therapy industry (CTI) has already achieved a billion-dollar annual revenue. This is only the beginning; identifying the bottlenecks and efficiently resolving them will result in a new healthcare sector on a par with pharmaceutical, biotechnological and medical devices. Thus, it is critical that the CTI focuses on the translation of the biologically ...